Back to Search Start Over

Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome

Authors :
Spyros A. Kalams
M. Azim Ansari
Simon Mallal
Andri Rauch
E Barnes
Louise Barnett
Ian James
Anne Plauzolles
Mark A. Pilkinton
Karen Fitzmaurice
Mina John
Elouise Gaylard
Heidi E. Drummer
Silvana Gaudieri
Pooja Deshpande
Dermot Kelleher
Katja Pfafferott
Andrew Lucas
Michaela Lucas
Wyatt J. McDonnell
Cody A. Chastain
Shahzma Merani
Vincent Pedergnana
Paul Klenerman
Amy Prosser
The University of Western Australia (UWA)
Murdoch University
Bern University Hospital [Berne] (Inselspital)
University of Bern
University of Oxford
John Radcliffe Hospital [Oxford University Hospital]
University of Alberta
Vanderbilt University Medical Center [Nashville]
Vanderbilt University [Nashville]
Monash university
University of Melbourne
Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC)
Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])
The Wellcome Trust Centre for Human Genetics [Oxford]
Royal Perth Hospital
Fiona Stanley Hospital [Murdoch]
Trinity College Dublin
University of British Columbia (UBC)
Source :
Scientific Reports, Lucas, Michaela; Deshpande, Pooja; James, Ian; Rauch, Andri; Pfafferott, Katja; Gaylard, Elouise; Merani, Shahzma; Plauzolles, Anne; Lucas, Andrew; McDonnell, Wyatt; Kalams, Spyros; Pilkinton, Mark; Chastain, Cody; Barnett, Louise; Prosser, Amy; Mallal, Simon; Fitzmaurice, Karen; Drummer, Heidi; Ansari, M. Azim; Pedergnana, Vincent; ... (2018). Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome. Scientific Reports, 8(1), p. 7224. Nature Publishing Group 10.1038/s41598-018-25559-6 , Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018), Scientific Reports, 2018, 8 (1), pp.7224. ⟨10.1038/s41598-018-25559-6⟩
Publication Year :
2018
Publisher :
Nature Publishing Group UK, 2018.

Abstract

Hepatitis C virus (HCV)-specific T cell responses are critical for immune control of infection. Viral adaptation to these responses, via mutations within regions of the virus targeted by CD8+ T cells, is associated with viral persistence. However, identifying viral adaptation to HCV-specific CD4+ T cell responses has been difficult although key to understanding anti-HCV immunity. In this context, HCV sequence and host genotype from a single source HCV genotype 1B cohort (n = 63) were analyzed to identify viral changes associated with specific human leucocyte antigen (HLA) class II alleles, as these variable host molecules determine the set of viral peptides presented to CD4+ T cells. Eight sites across the HCV genome were associated with HLA class II alleles implicated in infection outcome in this cohort (p ≤ 0.01; Fisher’s exact test). We extended this analysis to chronic HCV infection (n = 351) for the common genotypes 1A and 3A. Variation at 38 sites across the HCV genome were associated with specific HLA class II alleles with no overlap between genotypes, suggestive of genotype-specific T cell targets, which has important implications for vaccine design. Here we show evidence of HCV adaptation to HLA class II-restricted CD4+ T cell pressure across the HCV genome in chronic HCV infection without a priori knowledge of CD4+ T cell epitopes.

Details

Language :
English
ISSN :
20452322
Volume :
8
Database :
OpenAIRE
Journal :
Scientific Reports
Accession number :
edsair.doi.dedup.....cacc2dfd3caf5077e3d86ba2c04ea74d
Full Text :
https://doi.org/10.1038/s41598-018-25559-6